LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 39 filers reported holding LARIMAR THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $244,568 | -57.3% | 61,916 | -66.1% | 0.00% | 0.0% |
| Q2 2023 | $572,217 | -40.7% | 182,817 | -14.2% | 0.00% | -66.7% |
| Q1 2023 | $964,867 | +99.0% | 212,995 | +81.4% | 0.00% | +50.0% |
| Q4 2022 | $484,920 | +99.6% | 117,414 | +54.6% | 0.00% | +100.0% |
| Q3 2022 | $243,000 | +440.0% | 75,942 | +234.4% | 0.00% | – |
| Q2 2022 | $45,000 | -60.9% | 22,712 | -20.1% | 0.00% | – |
| Q1 2022 | $115,000 | -43.1% | 28,412 | +51.8% | 0.00% | – |
| Q4 2021 | $202,000 | -42.8% | 18,711 | -38.9% | 0.00% | -100.0% |
| Q3 2021 | $353,000 | +94.0% | 30,607 | +116.3% | 0.00% | 0.0% |
| Q2 2020 | $182,000 | – | 14,149 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,473,366 | $14,345,001 | 3.82% |
| Opaleye Management Inc. | 1,560,000 | $6,442,800 | 2.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $69,967,804 | 1.45% |
| GREAT POINT PARTNERS LLC | 1,273,635 | $5,260,113 | 1.03% |
| DAFNA Capital Management LLC | 473,136 | $1,954,052 | 0.55% |
| COMMODORE CAPITAL LP | 750,000 | $3,098 | 0.47% |
| Cheyne Capital Management (UK) LLP | 63,680 | $262,998 | 0.46% |
| Atlas Venture Advisors, Inc. | 292,184 | $1,206,720 | 0.42% |
| Perceptive Advisors | 2,860,000 | $11,811,800 | 0.33% |
| MANGROVE PARTNERS IM, LLC | 1,292,812 | $5,339,314 | 0.30% |